Publicerad: 2020-06-11 12:09 | Uppdaterad: 2020-06-11 14:04

Aktuella utlysningar, vecka 24, 2020

Grants Office tipsar om aktuella utlysningar.

Svenska och nordiska utlysningar

Grants for research on amyotrophic lateral sclerosis Ulla-Carin Lindqvists Stiftelse

Supports research on amyotrophic lateral sclerosis (ALS) as well as information spreading projects in Sweden and abroad. The total budget is worth approximately SEK 3.5 million.

Closing date: 1 August 2020

Further information

 

Bilateral cooperation with India within health and AI - Vinnova

Department of Biotechnology (DBT), Government of India, and Vinnova (The Agency for Innovation Systems), Government of Sweden, is announcing grant funding to implement projects aimed at producing new solutions which, aided by artificial intelligence (AI), have significant potential to improve public health, nursing or care in Sweden and India. Projects may focus on such things as disease prevention, diagnosis, treatment, improved medicines and vaccines, nursing or processes. Projects should be able to add economic value either by:

  • bringing about new products and services, which can be commercialised, or
  • by other means such as improved healthcare or streamlining of nursing or care.

Closing date: 28 August 2020

Further information

 

Postdoktoralt stöd - Myndigheten för samhällsskydd och beredskap

Stöder möjligheten för nydisputerade forskare med intresse för området samhällsskydd och beredskap att fortsätta sin forskarkarriär inom området och därmed bidra till kunskapsutveckling och kompetensuppbyggnad inom fältet. Stöd täcker minst 80 procent av en heltidstjänst under mellan ett och ett halvt och två år.

Closing date: 30 September 2020

Further information

Europeiska utlysningar
 

Research grant for pandemic preparedness - Merck

Merck invites pre-proposals for its research grant for pandemic preparedness. This supports technological solutions for pandemic outbreak preparedness, or solutions that could help fight emerging viral infections. Proposals should address the following needs: •assess the priority of pathogens and diseases with epidemic threat; •platform technologies to accelerate the development of vaccines, drugs, diagnostics, vector control tools and delivery systems needed to control emerging health threats; •innovative technologies for better personal protection equipment for infection control; •novel health technologies, such as AI, bioelectronics and diagnostics, for early screening of potential infected patients and treatment facilitation; •fast-track identifying, testing and production of effective drugs and vaccines during outbreak.

Closing date: No deadline

Further information

 

Call for research proposals on fatigue and pain in RMDs – FOREUM

Fatigue and pain are central manifestations on many different forms of Rheumatic Musculoskeletal Diseases (RMDs), and are underappreciated in research to date. Due to this unmet need, FOREUM announces a call for basic, translational and clinical studies that help to better understand fatigue and pain in RMDs. With this call FOREUM aims to instigate high-quality research that improves understanding of the pathogenesis, clinical relevance and management of fatigue and pain in RMDs.

Closing date: 20 September 2020

Further information

 

L'Oreal-UNESCO awards for women in science Sweden - Young Academy of Sweden

The L'Oreal Foundation, in partnership with the Young Academy of Sweden and The Swedish National Commission for UNESCO, invites applications for their award for women in science in Sweden. These aim to encourage the participation of women in science and sustainable development by recognising female scientists in the fields of life sciences, including medicine, physical sciences, engineering and mathematics. Female researchers employed by a HEI or a research institute in Sweden who have earned their PhD degree up to four years ago may apply.

Closing date: 27 September 2020

Further information

 

Starting grants - Frick Foundation for ALS Research

The Frick Foundation for ALS Research invites applications for its starting grants. These support basic biomedical research related to amyotrophic lateral sclerosis. Applicants may be researchers of any nationality with five years of postdoctoral experience and potential to be a research leader. Research must be conducted in a public or private research organisation.

Closing date: 30 September 2020

Further information

Amerikanska utlysningar

Federal Funding agencies

Biomedical Data Repository (U24 - Clinical Trials Not Allowed), NIH

This funding opportunity announcement is designed to support biomedical data repositories. Biomedical data repositories under this announcement should have the primary function to ingest, archive, preserve, manage, distribute, and make accessible the data related to a particular system or systems. Support for data curation must be limited to that which improves the efficiency and accessibility of data ingestion, management, and use and reuse by the user communities. Support for software and tool development must be limited to that which provides essential functions or significantly increases the efficiency of operation of the repository. Applications that have a significant focus on software and tool development are not appropriate for this activity.

Deadline: September 25, 2020; January 25, 2021; September 24, 2021; January 25, 2022; September 26, 2022; January 25, 2023. All applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PAR-20-089

Further information 
 

Biomedical Knowledgebase (U24 - Clinical Trials Not Allowed), NIH

This funding opportunity announcement is designed to support biomedical knowledgebases. Biomedical knowledgebases under this announcement should have the primary function to extract, accumulate, organize, annotate, and link growing bodies of information related to core datasets. Support for data curation should include efficient and effective methods of curation that scale to the needs of the community and include semi-automated methods. Support for software and tool development must be limited to that which provides essential functions or significantly increases the efficiency of operation of the knowledgebase.

Deadline: September 25, 2020; January 25, 2021; September 24, 2021; January 25, 2022; September 26, 2022; January 25, 2023. All applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PAR-20-097

Further information

 

Kidney Cancer Research Program (KCRP), Department of Defense (DoD), US

Academy of Kidney Cancer Investigators – Early-Career Investigator Award – Letter of Intent due August 5, 2020

Must be within 3 years of their last postdoctoral research position (Ph.D.) or clinical fellowship (M.D.), or equivalent, as of the full application submission deadline

  • Maximum funding of $725,000 for direct costs (plus indirect costs).
  • Maximum period of performance 4 years.

Concept Award – Letter of Intent due July 15, 2020

  • Maximum funding of $100,000 for direct costs (plus indirect costs)
  • Maximum period of performance 1 year

Translational Research Partnership Award – Letter of Intent due August 5, 2020

The Initiating Principal Investigator (PI) must be at or above the level of Assistant Professor or equivalent).

The Partnering PI must be at or above the level of Assistant Professor or equivalent. 

Postdoctoral fellows are not eligible to be Partnering PIs.

  • Maximum funding of $750,000 for direct costs (plus indirect costs)
  • Maximum period of performance 3 years

Clinical Consortium Award - Letter of Intent Due September 2, 2020
*       Up to two (2) Clinical Trial Sites will be selected and be jointly responsible for proposing, selecting, and conducting trials within the existing Kidney Cancer Research Consortium
*       The consortium is expected to achieve financial self-sufficiency, such that operating can continue after the award period ends.
*      Maximum funding of $600,000 for direct costs (plus indirect costs)
*       Maximum period of performance 2 years

Idea Development Award - Letter of Intent Due September 2, 2020
*       Supports new ideas that represent innovative, high-risk/high-gain approaches to kidney cancer research, and have the potential to make an important contribution to kidney cancer
*       Innovation and Impact are the most important review criteria
 

Early Detection Studies Option:
*        Maximum funding of $650,000 in direct costs (plus indirect costs)
*        Maximum period of performance 3 years

Population Science and Prevention Studies Option:
*       Maximum funding of $2 million in direct costs (plus indirect costs)
*       Maximum period of performance 4 years

Postdoctoral and Clinical Fellow Award - Letter of Intent Due September 2, 2020
Must have completed requirements for Ph.D. and/or M.D.
Must be in the laboratory or clinical setting where proposed research will be performed.
Must have no more than 4 years of postdoctoral and/or mentored clinical research experience
*       Supports research opportunities focused on kidney cancer for individuals in the early stages of their careers
*       Maximum funding of $195,000 for direct costs (plus indirect costs)
*       Maximum period of performance 3 years

Further information 

 

Scleroderma Research Program (SRP), Department of Defense (DoD), US

Idea Development Award

Investigators at all academic levels (or equivalent)

New Investigators:

  • Maximum funding of $300,000 for direct costs (plus indirect costs)

New Investigator Collaboration Option

  • Maximum funding of $450,000 for direct costs (plus indirect costs)
  • Maximum period of performance is 3 years

Translational Research Partnership Award

Investigators above the level of post-doctoral fellow (or equivalent)

Clinicians must be an M.D., M.D./Ph.D, or equivalent with clinical duties and/or responsibilities 

New Investigators:

  • Maximum funding of $750,000 for direct costs (plus indirect costs)
  • Maximum period of performance is 3 years

Further information 

 

Foundation

Health effects of air pollution, Health Effects Institute, US

This supports research on novel and important aspects of the health effects of air pollutants. The current areas of interest are:

•accountability or effectiveness of air quality regulations;

•strengthening causal interpretation of evidence from existing cohorts;

•contributions of wildland and agricultural burning to air quality and health.

Small to medium grants are worth up to USD 500,000 each for two years. Large grants are worth up to USD 800,000 for up to three years.

Deadline: Preliminary applications due by 19 August 2020; full applications due by 6 January 2021.

Further information 

 

Research Grants, Massage Therapy Foundation, US

The Massage Therapy Foundation invites applications for its research grants. These support independent research which contributes directly to the basic knowledge of massage therapy or its application, including applied research investigating massage therapy as a health or mental health treatment or prevention modality.

Investigators who have experience in a relevant field of research and are associated with, or have secured the cooperation of, a university, independent research organisation, health centre or other institution that is qualified and willing to function as a sponsoring organisation are eligible to apply.

Grants are worth up to USD 30,000 for one year.

Deadline: Pre-proposal application deadline is now extended to September 1, 2020; full applications due by December 1, 2020.

Further information